SCHEMBL4193563

SCHEMBL4193563

CCCCS(=O)(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2CN[C@@H](C)CC2CCCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
PKM P14618 1/20 0.47
LMNA P02545 6/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 5/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 1/20 0.37
AR P10275 1/20 0.37
MAPT P10636 4/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
AURKA O14965 1/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188316 0.92 KDM4E (0.51) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4190400 0.87 KDM4E (0.52) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4190913 0.86 KDM4E (0.50) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL12050344 0.85 KDM4E (0.55) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4197358 0.84 MEN1 (0.46) KDM4EPKMLMNAALDH1A1MEN1
SCHEMBL4192900 0.84 KDM4E (0.49) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL12050341 0.83 KDM4E (0.50) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4184516 0.83 KDM4E (0.53) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4193899 0.83 PKM (0.53) KDM4EPKMLMNAPOLBALDH1A1
SCHEMBL4202174 0.83 KDM4E (0.53) KDM4EPKMLMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885LMNA 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.